Levonorgestrel effects on serum androgens, sex hormone-binding globulin levels, hair shaft diameter, and sexual function

被引:13
作者
Kovalevsky, George [1 ]
Ballagh, Susan A. [2 ]
Stanczyk, Frank Z. [3 ]
Lee, Jennifer [2 ]
Cooper, Joann [2 ]
Archer, David F. [2 ]
机构
[1] Reprod Associates Delaware, Newark, DE USA
[2] Eastern Virginia Med Sch, Dept Obstet & Gynecol, CONRAD Clin Res Ctr, Norfolk, VA 23501 USA
[3] Univ So Calif, Dept Obstet & Gynecol, Keck Sch Med, Los Angeles, CA 90089 USA
关键词
Levonorgestrel subcutaneous implant; sex hormone-binding globulin; serum androgens; hair shaft diameter; sexual function; testosterone; CONTRACEPTIVE IMPLANTS; ORAL-CONTRACEPTIVES; FREE TESTOSTERONE; HIRSUTE WOMEN; BODY HAIR; 5-ALPHA-REDUCTASE ACTIVITY; IDIOPATHIC HIRSUTISM; CLINICAL-CHEMISTRY; CONTROLLED TRIAL; DOUBLE-BLIND;
D O I
10.1016/j.fertnstert.2008.12.095
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To determine the effects of levonorgestrel (LNG) on serum androgens, sex hormone binding globulin (SHBG), hair shaft diameter, and sexual function in women. Design: Substudy of a prospective randomized double-blind study in women using an LNG SC implant (LNG-SI), who were treated with doxycycline or placebo. Setting: Medical school department of obstetrics and gynecology. Patient(s): Forty women were enrolled; 36 completed the study. Intervention(s): Participants were randomized to doxycycline 20 mg or an identical placebo orally twice a day after LNG-SI insertion. Main Outcome Measure(s): Serum levels of total T (TT), free T (FT), androstenedione (A), dehydroepiandrosterone sulfate (DHEAS), dihydrotestosterone (DHT), androstanediol glucuronide (AG). SHBG, and LNG; hair shaft diameter; and sexual function using the Brief Index of Sexual Function for Women and the Arizona Sexual Experiences Scale were assessed. Result(s): Serum TT, A, DHT, DHEAS, and SHBG declined after LNG-SI insertion. No changes were found in FT. AG, hair shaft diameter, or sexual function. Serum LNG correlated with SHBG levels. There were no differences between the placebo and doxycycline groups. Conclusion(s): LNG reduced serum TT, A, DHT, DHEAS, and SHBG but had no effect on sexual function or markers of androgen bioactivity. (Fertil Steril (R) 2010;93:1997-2003. (C)2010 by American Society for Reproductive Medicine.)
引用
收藏
页码:1997 / 2003
页数:7
相关论文
共 51 条
[1]  
Aisien A O, 2007, Afr J Reprod Health, V11, P90, DOI 10.2307/30032491
[2]   Ultrasonographic and endocrine evaluation of ovarian function among Norplant(R) implants users with regular menses [J].
Alvarez, F ;
Brache, V ;
Faundes, A ;
Tejada, AS ;
Thevenin, F .
CONTRACEPTION, 1996, 54 (05) :275-279
[3]   ABNORMAL ENDOCRINE PROFILE AMONG WOMEN WITH CONFIRMED OR PRESUMED OVULATION DURING LONG-TERM NORPLANT USE [J].
ALVAREZ, F ;
BRACHE, V ;
TEJADA, AS ;
FAUNDES, A .
CONTRACEPTION, 1986, 33 (02) :111-119
[4]   Oral contraceptive efficacy and antibiotic interaction: A myth debunked [J].
Archer, JSM ;
Archer, DF .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2002, 46 (06) :917-923
[5]   Female androgen insufficiency: the Princeton consensus statement on definition, classification, and assessment [J].
Bachmann, G ;
Bancroft, J ;
Braunstein, G ;
Burger, H ;
Davis, S ;
Dennerstein, L ;
Goldstein, I ;
Guay, A ;
Leiblum, S ;
Lobo, R ;
Notelovitz, M ;
Rosen, R ;
Sarrel, P ;
Sherwin, B ;
Simon, J ;
Simpson, E ;
Shifren, J ;
Spark, R ;
Traish, A .
FERTILITY AND STERILITY, 2002, 77 (04) :660-665
[6]   SPIRONOLACTONE IS AN EFFECTIVE AND WELL TOLERATED SYSTEMIC ANTIANDROGEN THERAPY FOR HIRSUTE WOMEN [J].
BARTH, JH ;
CHERRY, CA ;
WOJNAROWSKA, F ;
DAWBER, RPR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1989, 68 (05) :966-970
[7]   CRYPROTERONE ACETATE FOR SEVERE HIRSUTISM - RESULTS OF A DOUBLE-BLIND DOSE-RANGING STUDY [J].
BARTH, JH ;
CHERRY, CA ;
WOJNAROWSKA, F ;
DAWBER, RPR .
CLINICAL ENDOCRINOLOGY, 1991, 35 (01) :5-10
[8]  
Barth JH, 1997, ACTA DERM-VENEREOL, V77, P317
[9]   SEX-HORMONE BINDING GLOBULIN - EFFECT OF SYNTHETIC STEROIDS ON THE ASSAY AND EFFECT OF ORAL-CONTRACEPTIVES [J].
BOWLES, SM ;
MILLS, RJ .
ANNALS OF CLINICAL BIOCHEMISTRY, 1981, 18 (JUL) :226-231
[10]   Nonmenstrual adverse events during use of implantable contraceptives for women: data from clinical trials [J].
Brache, V ;
Faundes, A ;
Alvarez, F ;
Cochon, L .
CONTRACEPTION, 2002, 65 (01) :63-74